Comparison of Anticoagulation for All-comers Undergoing Percutaneous Coronary Revascularization Trial
Status:
Terminated
Trial end date:
2016-06-16
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to determine whether bivalirudin is non-inferior to
unfractionated heparin in patients with stable angina, unstable angina, or non-ST segment
elevation myocardial infarction undergoing percutaneous coronary intervention.